Jerome Galon, France

INSERM Cordeliers Research Center
Dr Jérôme Galon is first class Director of Research at INSERM (French National Institute of Health and Medical Research) and head of an INSERM laboratory (INSERM UMRS1138, Integrative Cancer Immunology) at the Cordeliers Research Center in Paris, France. Dr. Jérôme Galon is the co-founder of the company, HalioDx, and is the Chairman of its scientific council. He is associate Director and co-founder of European Academy of Tumor Immunology (EATI), Board Director of Society for Immunotherapy of Cancer (SITC, USA), member of American Association of Immunology (AAI), French Association of Immunologists (SFI), American Association for Cancer Research (AACR). He also serves on numerous advisory boards. Dr. Galon was trained as an immunologist at the Pasteur Institute (Paris, France). He holds a Ph.D. degree in Immunology (1996), and worked at the NIH (1997-2000, Bethesda, USA). Since his full-tenured position at INSERM in 2001, he directs interdisciplinary research programs. Dr. Jérôme Galon has made important contributions to medical research through his groundbreaking work in the fields of immunology and cancer research. His contributions have been recognized with numerous awards. He received the prestigious William B. Coley Award for Distinguished Research in Basic and Tumor Immunology (Cancer Research Institute, New York, USA), Award from the National Academy of Science, and Award from the National Academy of Medicine, fellow Award for Research Excellence at NIH (USA), Awards from the French foundation, from the Medical Research Foundation, from the French Society of Immunology (Jacques Oudin Award). He gave the prestigious Annual B. Benacerraf Lecture in Immunology (Harvard, USA, 2014). He is best known for his works on comprehensive analysis of the tumor-microenvironment in human cancer and bioinformatics, and for the discovery that the adaptive immune reaction within the tumor was a better predictor of survival than traditional staging based on cancer's size and spread. He defined the concept of cancer immune-contexture, pioneered the Immunoscore and is PI of the Immunoscore worldwide consortium. Dr. Galon has published over 200 papers and proceedings in top-tier scientific journals, and delivered over 300 invited lectures internationally.

Presenter of 1 Presentation

Plenary Session No Topic Needed

THE IMMUNOLOGY OF THE TUMOR-MICROENVIRONMENT: IMPACT ON CANCER PROGRESSION, INVASION, RECURRENCE, AND SURVIVAL OF PATIENT

Lecture Time
12:30 - 13:00
Room
Gold
Date
21.09.2019, Saturday
Session Time
12:30 - 13:15
Presentation Topic
No Topic Needed